Charles River Laboratories Intl (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Sales | 349,465 | 339,573 | 320,414 | 329,548 | 327,567 |
| Cost of Goods | 211,390 | 206,790 | 200,754 | 209,603 | 209,299 |
| Gross Profit | 138,075 | 132,783 | 119,660 | 119,945 | 118,268 |
| Operating Expenses | 83,025 | 77,838 | 77,409 | 79,781 | 72,395 |
| Operating Income | 55,440 | 55,735 | 43,005 | 40,767 | 46,172 |
| Interest Expense | 3,851 | 4,376 | 3,024 | 2,779 | 2,997 |
| Other Income | 1,567 | 8,969 | -8,029 | 2,198 | 707 |
| Pre-tax Income | 53,156 | 60,328 | 31,952 | 40,186 | 43,882 |
| Income Tax | 15,255 | 11,076 | 331 | 11,650 | 11,582 |
| Net Income Continuous | 37,901 | 49,252 | 31,621 | 28,536 | 32,300 |
| Net Income Discontinuous | -34 | -7 | -7 | -864 | 52 |
| Minority Interests | 488 | 736 | 73 | 506 | 316 |
| Net Income | $37,379 | $48,509 | $31,541 | $27,166 | $32,036 |
| EPS Basic Total Ops | 0.81 | 1.04 | 0.67 | 0.59 | 0.70 |
| EPS Basic Continuous Ops | 0.81 | 1.04 | 0.67 | 0.61 | 0.70 |
| EPS Basic Discontinuous Ops | 0.00 | 0.00 | 0.00 | -0.02 | 0.00 |
| EPS Diluted Total Ops | 0.79 | 1.02 | 0.66 | 0.57 | 0.68 |
| EPS Diluted Continuous Ops | 0.79 | 1.02 | 0.66 | 0.60 | 0.68 |
| EPS Diluted Discontinuous Ops | 0.00 | 0.00 | 0.00 | -0.02 | 0.00 |
| EBITDA(a) | $79,652 | $80,032 | $65,796 | $67,204 | $72,685 |